Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region. by 源��쁽李�
BioMed Central
ss
BMC Public HealthOpen AcceResearch article
Impact of cigarette smoking on the relationship between 
body mass index and coronary heart disease: a pooled analysis of 
3264 stroke and 2706 CHD events in 378579 individuals in the Asia 
Pacific region
The Asia Pacific Cohort Studies Collaboration
Address: Nutrition and Lifestyle Division, The George Institute for International Health, Missenden Road, Camperdown, Australia
Email: The Asia Pacific Cohort Studies Collaboration - rhuxley@george.org.au
Abstract
Background: Elevated levels of body mass index (BMI) and smoking are well established lifestyle
risk factors for coronary heart disease (CHD) and stroke. If these two risk factors have a
synergistic relationship, rigorous lifestyle modification may contribute to greater reduction in
cardiovascular burden than previously expected.
Methods: A pooled analysis of individual participant data from 38 cohorts, involving 378,579
participants. Hazards ratios (HRs) and 95% confidence intervals (CIs) for BMI by cigarette smoking
status were estimated using Cox proportional hazard models.
Results: During a mean follow-up of 3.8 years, 2706 CHD and 3264 strokes were recorded. There
was a log-linear, positive relationship of BMI with CHD and stroke in both smokers and non-
smokers with evidence of a synergistic effect of smoking on the association between BMI and CHD
only: HRs (95% CIs) associated with a 2 kg/m2 higher BMI were 1.13 (1.10 – 1.17) in current
smokers and 1.09 (1.06 – 1.11) in non-smokers (p-value for interaction = 0.04).
Conclusion: Smoking amplifies the positive association between BMI and CHD but not stroke. If
confirmed, these results suggest that effective strategies that target smoking cessation and weight
loss are likely to have a greater impact than anticipated on reducing the burden of CHD.
Background
It has been well documented that overweight and obesity
is now a global epidemic with relatively few countries
unaffected. The World Health Organisation (WHO) has
estimated that 1.6 billion people are overweight world-
wide, which, for the first time, exceeds those who are
undernourished [1,2]. Moreover, low- and middle-
income countries, such as China that traditionally had
one of the leanest populations, are rapidly approaching
the prevalence of overweight observed in more developed
regions [3]. Although the prevalence of smoking in the
Western world has progressively declined over the past
forty years – due largely to effective and comprehensive
tobacco control measures – tobacco consumption
remains high in many countries across Asia where about
40–70% of men smoke [4]. This is a likely consequence of
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with smoking combined with a low use of smoking cessa-
tion aids and aggressive promotion of smoking by the
tobacco industry in many countries in Asia, such as China
[5].
Smoking [6-8] and excess weight [9-11] are well estab-
lished risk factors for cardiovascular disease. In smokers,
the risk of coronary heart disease (CHD) and stroke is
more than twice that of non-smokers [7], whereas there is
a somewhat more modest increase in risk associated with
overweight and obesity [11]. Some previous studies have
suggested that the association between body mass index
(BMI) and cardiovascular risk may be modified by smok-
ing, although there is dispute over whether smoking
amplifies or attenuates the relationship [12-15]. If smok-
ing does interact with BMI, this would have ramifications
for estimates of disease burden due to these two impor-
tant and modifiable risk factors, and have implications for
disease prevention. In the present study, we take advan-
tage of the Asia Pacific Cohort Studies Collaboration
(APCSC) – a large database comprising more than 40 lon-
gitudinal studies from the region – to explore this impor-
tant public health issue.
Methods
Participating studies
The APCSC is an individual participant data overview
conducted by the principal investigators of 44 existing
cohort studies in the region. Methods of study identifica-
tion, their characteristics have been reported elsewhere
[16,17]. In brief, studies were eligible for inclusion in the
project if they satisfied the following criteria: (1) a study
population from the Asia Pacific region; (2) prospective
study design; (3) at least 5,000 person-years of follow-up
recorded; (4) date of birth (or age), sex, and blood pres-
sure recorded at baseline; (5) date of death (or age at
death) recorded during follow-up. Additionally, for anal-
yses in this report, participants were restricted to individ-
uals aged 20 years or over at study entry with information
on both BMI and smoking status.
Measurement of baseline variables
Height and weight were measured using standard proto-
cols when the participant entered the study, and BMI was
calculated as weight (kg) divided by squared height (m2).
Cigarette smoking status (current smoker/non-smoker) at
baseline was assessed on the basis of self-report. Whether
an individual was a current smoker, a former smoker or a
never smoker was also reported in a smaller number of
studies. Cohorts were classified as Asian if the participants
were recruited from Mainland China, Hong Kong, Japan,
Korea, Singapore, Taiwan or Thailand and as Australasian
(ANZ) if the participants were from Australia or New Zea-
land. This classification largely represented a split by eth-
nicity into Asians and non-Asians.
Outcomes
Outcomes included in this report were total (fatal and
non-fatal) coronary heart disease (CHD), total ischaemic
stroke, total haemorrhagic stroke (primary intracerebral
haemorrhage and subarachnoid haemorrhage) and
unclassified stroke. Non-fatal events were defined as those
that did not result in death within 28 days. Outcomes
were coded according to the Ninth Revision of the Inter-
national Classification of Diseases (ICD-9): Combined
fatal and non-fatal CHD events (ICD-9: 410 – 414) and
stroke events [total stroke (ICD-9: 430–438); haemor-
rhagic stroke (431.0–432.9); and ischaemic stroke
(433.0–434.9)]. Since most studies used record linkage
with official sources, verification of strokes was not rou-
tinely reported. However, 12 of the 36 studies included in
this analysis provided information on stroke verification,
and in 6 of them (n = 155252) a pathological subtype of
stroke was determined by CT/MRI scan or brain autopsy
in over 75% of stroke cases (n = 2448). All data provided
to the Secretariat were checked for completeness and con-
sistency and re-coded where necessary to maximise com-
parability across cohorts. Summary reports were referred
back to principal investigators of each collaborating study
for review and confirmation.
Statistical methods
Participants at extreme ends of the BMI spectrum (i.e., <15
or >50 kg/m2) were excluded from the analysis (n = 303).
To address the possibility of reverse causality whereby a
low BMI may be indicative of some occult disease, all HRs
(95% Confidence Intervals [95% CI]) reported in the
results are derived after three years left-censoring of the
data. Having ascertained that the proportional hazards
assumption had not been violated, Cox proportional haz-
ards regression models were used to regress time until first
CHD or stroke event against levels of baseline BMI by
smoking status (current smoker or non-smoker) [18]. All
analyses were adjusted for age and stratified by study and
sex. Further, to consider the potential effects of smoking
on the relationships between BMI, CHD and stroke, inde-
pendent of intermediary variables along the causal path-
way between adiposity and cardiovascular outcomes we
additionally adjusted for systolic blood pressure (SBP).
We repeated these analyses within the sub-group of partic-
ipants on whom information on all intermediary varia-
bles including SBP, serum total cholesterol (TC) and
diabetic status were available. To explore log-linearity of
the associations between BMI and CHD and stroke events,
HRs were plotted for mean level in each of five BMI cate-
gories (the penultimate lowest category was the referent).
For HRs in each category, 95% CIs were estimated by the
'floating absolute risk' method [19].Page 2 of 11
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higher BMI as a continuous variable. Further HRs (95%
CIs) were calculated comparing the effects of smoking sta-
tus in individuals classified either as overweight (BMI ≥ 25
kg/m2 in ANZ and BMI ≥ 24 kg/m2 in Asia) or "normal"
weight (BMI ≤ 25 kg/m2 in ANZ and BMI ≤ 24 kg/m2 in
Asia [20]. The statistical significance of any interaction
between BMI and smoking status was assessed using like-
lihood ratio tests, comparing the models with main effects
only with the models that included the interaction term
[21]. As well as analyses of the overall APCSC, pre-defined
subgroup analyses were performed by sex, by region (Asia
and ANZ) and by age at risk (restricted to the following
age-groups: 35 – 59, 60 – 69, 70 – 79, 80 – 89 years).
Analyses were repeated on the sub-sample of the total
population which had information on whether any non-
smoker had previously smoked. In these sub-samples,
participants were classified as 'current' if they smoked cur-
rently, 'never smokers' if they had never smoked and
'former smokers' if they had smoked but reported having
already quit at study baseline. HRs for a 2 kg/m2 higher
level of BMI were estimated for each of these smoking
groups, and compared using similar methods to the main
analyses.
Results
Characteristics of the study population
Information on BMI and smoking status (current smoker
or not) was available from 38 cohorts (86% of all studies
in APCSC); 30 from Asia (Table 1). Overall, 378,579 par-
ticipants were included in the analysis (76% Asians; 40%
female) with a mean age of 47 years. Approximately one-
third (34%) of study participants were classified as current
smokers at baseline, with marked differences by sex and
region: in Asia, 60% of men and 5% of women were cur-
rent smokers, compared to 21% and 14%, respectively, in
ANZ. In Asia, mean age and BMI were similar between
smokers and non-smokers (46 versus 46 years; 22.8 versus
22.9 kg/m2), but in ANZ, current smokers were younger
(47 years versus 53 years) and had a lower BMI (25.6 kg/
m2 versus 26.4 kg/m2) than non-smokers. Of the 38
cohorts included in the main analyses, 32 (24 in Asia)
recorded former smoking status for non-smokers. Of
339,251 participants in these cohorts, approximately 17%
were former smokers, 50% were never smokers and 32%
were current smokers. In Asian cohorts, 23% of men and
23% of women who had ever smoked had quit, compared
to 66% and 59%, respectively, in ANZ.
Follow-up and outcomes
In total, there were 1,431,261 person-years of follow-up;
the mean follow-up was 3.8 years (3.9 years for current
smokers and 3.6 years for non-smokers) but it was
shorter, for both current smokers and non-smokers, in
Asia (2.9 and 2.8 years, respectively) than in ANZ (8.3 and
6.3 years) (Table 2). In addition to information on fatal
events that was available from all cohorts, data on non-
fatal events were present in 18 studies (Table 2). During
follow-up there were 2706 CHD events (33% in Asia), of
which myocardial infarction accounted for more than
80%, and 3264 stroke events (70% in Asia).
The association between BMI and CHD in current and
non-smokersHigher levels of BMI were positively and log-
linearly associated with the risk of incurring a fatal or non-
fatal CHD event, irrespective of smoking status (Table 3).
There was strong evidence that compared with non-smok-
ers, smoking amplified the strength of the association
between BMI with CHD; this was apparent irrespective of
whether BMI was dichotomised into "normal" and "over-
weight" or measured on a continuous scale. For example,
current smokers who were overweight (25 < BMI ≤ 29.9
kg/m2 in ANZ and 24 ≤ BMI ≤ 28 kg/m2 in Asia) had
approximately one-third greater excess risk of CHD com-
pared with overweight (BMI > 30 kg/m2 in ANZ and BMI
> 28 kg/m2 in Asia) non-smokers: HR 1.64 (95% CI: 1.47
– 1.82) vs. 1.47 (95% CI: 1.36 – 1.59); p-value for inter-
action = 0.019 (Table 3). Similarly, for a 2 kg/m2 incre-
ment in BMI, the excess risk for CHD was greater in
current smokers than in non-smokers by approximately
four percentage points (i.e., 13% versus 9%) (Figure 1a):
HR 1.13 (95% CI: 1.10 – 1.17) versus HR 1.09 (95% CI:
1.06 – 1.11); p-value for interaction = 0.04. When fatal
CHD events alone (n = 1970) were analysed, similar pat-
terns were observed: HR (95% CI) for a 2 kg/m2 higher
BMI was 1.14 (1.09 – 1.18) for current smokers and 1.09
(1.06 – 1.12) for non-smokers; p-value for interaction =
0.07.
After adjustment for SBP the relationship between BMI
and CHD was weakened but the interaction with smoking
remained significant (p = 0.19). In the sub-group of indi-
viduals in whom data were available for SBP, TC and dia-
betes status (n = 318,384 and 2446 CHD events) there
was no evidence of an interaction between smoking and
BMI on subsequent risk of CHD before, or after, adjust-
ment for these variables (p = 0.22 and p = 0.21, respec-
tively), which is potentially due to the reduced power to
detect any interaction.
The pattern of a stronger association between BMI and
CHD among smokers compared with non-smokers was
broadly consistent across the age, sex and region sub-
groups, although the test for interaction was non-signifi-
cant in each of the sub-groups examined (Figure 1). There
was some suggestion that the interaction was only appar-
ent in individuals aged > 65 years (Figure 1). When we fur-
ther stratified individuals into four age groups (35–59,
60–69, 70–79 and 80–89 yrs), the effect of a 2 kg/m2Page 3 of 11
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non-smokers in the youngest age-group (HR 1.16 95% CI:
1.09 – 1.22) whereas in the other three groups, the HRs
were consistently stronger in smokers compared with
non-smokers (results not shown but available on
request).
In the sub-sample of studies for which information on
former smokers was available, there were 2513 CHD
events. The excess risk for CHD associated with a 2 kg/m2
higher BMI was greater in current smokers than in former
smokers and never smokers: HR 1.13 (95% CI: 1.09 –
Table 1: Study population characteristics at baseline by smoking status
Non-smokers Current smokers
Age (years) BMI (kg/m2) Female Age (years) BMI (kg/m2) Female
Study name n mean SD mean SD (%) n mean SD mean SD (%)
Akabane 1294 55 8 22.7 3.1 77 499 53 7 22.0 2.6 2
Anzhen 5778 54 13 24.1 3.7 70 2306 52 12 23.4 3.4 20
Anzhen02 2995 47 8 23.9 3.3 65 733 46 8 24.1 3.1 1
Beijing Aging 1281 69 8 24.0 3.9 63 545 68 8 22.4 3.7 24
Capital Iron & Steel Co. 1281 45 8 23.7 2.7 0 3570 45 8 23.0 2.7 0
CISCH 1535 44 7 24.6 3.5 70 572 45 8 24.6 3.1 2
Civil Service Workers 5614 47 5 22.5 2.7 47 3401 47 5 22.4 2.8 10
CVDFACTS 4188 47 15 23.5 3.4 71 1192 48 15 23.5 3.2 4
East Beijing 756 44 15 23.7 3.2 65 318 41 15 23.5 3.4 19
EGAT 1786 42 5 23.2 3.1 38 1315 43 5 22.8 3.1 3
Fangshan 842 47 11 24.6 3.4 87 556 48 10 23.2 3.3 37
Guangzhou Occupational 10534 42 6 22.8 3.0 61 9876 43 6 22.2 2.7 1
Hisayama 793 56 11 21.8 2.8 82 600 54 9 21.4 2.4 23
Hong Kong 637 78 6 22.5 3.7 74 164 75 5 21.1 3.4 40
Kinmen 121 67 11 23.5 3.5 67 56 67 10 22.4 4.1 18
KMIC 97831 44 7 22.9 2.5 54 60711 45 7 23.3 2.4 0
Konan 719 52 16 22.1 3.1 76 310 50 15 21.7 2.8 8
Miyama 688 60 9 22.4 3.0 74 297 60 9 21.7 2.7 13
Ohasama 1704 59 11 23.5 3.2 78 423 57 12 22.5 2.9 8
Saitama 2527 54 12 22.5 2.9 80 1001 54 12 22.0 2.8 17
Seven Cities Cohorts 3201 54 12 21.9 3.1 70 1809 53 12 20.8 2.8 22
Shibata 1472 56 11 22.8 3.2 83 730 56 10 21.8 2.6 8
Shigaraki Town 1742 58 14 22.8 3.1 77 711 56 13 21.8 2.8 13
Shirakawa 2989 48 12 21.6 2.8 79 1586 48 12 21.2 2.5 8
Singapore Heart 1768 40 13 23.8 4.4 61 495 41 14 22.8 4.0 7
Singapore NHS92 2649 39 12 23.3 4.1 62 594 38 12 22.9 4.2 8
Six Cohorts 10359 44 7 21.3 2.7 77 8804 45 7 21.1 2.4 12
Tanno/Soubetsu 1183 51 7 24.1 3.2 78 737 51 7 22.9 2.9 14
Tianjin 4254 55 12 24.4 4.0 65 4438 53 11 23.0 3.7 39
Yunnan 1979 57 10 22.0 3.0 10 4263 54 9 21.4 2.8 0
Total Asia 174500 46 10 22.9 2.9 59 112612 46 9 22.8 2.8 5
ALSA 871 77 6 26.3 4.0 51 60 76 5 24.9 4.3 52
ANHF 6932 44 13 25.5 4.3 53 2184 41 13 25.1 4.2 45
Busselton 4729 45 17 24.8 3.9 60 2450 43 16 24.2 3.6 37
Fletcher Challenge 7673 45 15 26.4 4.1 30 2362 40 12 26.5 4.3 22
Melbourne 36235 55 9 26.9 4.4 61 4561 53 8 26.6 4.3 48
Newcastle 4484 52 11 26.9 4.5 54 1324 49 10 25.9 4.3 41
Perth 7561 46 13 25.3 3.9 51 2569 43 12 24.7 3.8 40
WAAAAS 6707 72 4 26.9 3.6 0 765 71 4 26.0 4.0 0
Total ANZ 75192 53 14 26.4 4.3 50 16275 47 14 25.6 4.2 38
Total 249692 48 11 24.0 3.8 56 128887 46 10 23.1 3.1 9
BMI, body mass index; SD, standard deviation; ANZ, Australia and New Zealand; ALSA, Australian Longitudinal Study of Aging; ANHF, Australian 
National Heart Foundation; CISCH, Capital Iron and Steel Company Hospital; EGAT, Electricity Generating Authority of Thailand; KMIC, Korean 
Medical Insurance Corporation; NHS92, National Health Study 1992, WAAAAS, Western Australian AAA Screenees. Blanks indicate that the event 
was not reported for that study.Page 4 of 11
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respectively (p-value for interaction = 0.10).
The association between BMI and stroke risk in current 
and non-smokers
As with CHD, irrespective of smoking status, BMI was pos-
itively and log-linearly associated with the risk of ischae-
mic stroke, and to a lesser extent, haemorrhagic stroke and
'unclassified' stroke. When comparing the magnitude of
the association between BMI and stroke risk, there was no
evidence of an interaction with smoking for either ischae-
mic or haemorrhagic stroke: For a 2 kg/m2 higher BMI, the
HRs (95% CI) in smokers compared with non-smokers
for ischaemic and haemorrhagic stroke were: 1.09 (1.04 –
1.15) vs 1.11 (1.06 – 1.16), p for interaction = 0.66; and
1.08 (1.02 – 1.15) vs. 1.08 (1.03 – 1.14), p for interaction
= 0.95 (Figures 2, 3). In sensitivity analyses, there was no
evidence to indicate an interaction between smoking and
BMI by age group, sex or region for either ischaemic or
haemorrhagic stroke (all p-values > 0.10). Restriction of
the analyses to only fatal stroke events did not alter these
findings.
For those strokes that were unclassified there was mar-
ginal evidence of an interaction between BMI and smok-
ing, but in the opposing direction to that observed with
CHD (Figure 4). The HRs (95% CI) associated with a 2 kg/
m2 higher BMI in smokers compared with non-smokers
were 1.02 (0.97 – 1.07) vs 1.08 (1.04 – 1.12), p for inter-
action = 0.08. The apparent stronger effect of BMI on risk
Table 2: Fatal and non-fatal coronary heart disease and stroke events by smoking status after three years left-censoring
Number of events (female %)
Region (Mean follow-up duration, years) Non-smokers Current smokers
Stroke sub-type Stroke sub-type
CHD Haem Isch NA CHD Haem Isch NA
Asia 272 (58) 180 (71) 445 (50) 262 (15) 268 (13) 165 (15) 458 (7)
(2.7 M, 3.1 F) 360 (53) 428 (59) 300 (65) 420 (12) 345 (11) 464 (10) 207 (8)
Fatal events 274 (59)
Fatal and non-fatal events 369 (53)
ANZ 64 (48) 49 (57) 511 (52) 451 (23) 26 (31) 12 (8) 265 (37)
(6.1 M, 7.5 F) 93 (50) 197 (52) 525 (54) 638 (24) 50 (34) 90 (34) 233 (37)
Fatal events 983 (40)
Fatal and non-fatal events 1279 (40)
Total events 1648 (43) 453 (52) 625 (57) 825 (58) 1058 (20) 395 (14) 554 (14) 447 (24)
ANZ = Australia and New Zealand; M = male; F = female; CHD = coronary heart disease; Haem = haemorrhagic stroke; Isch = ischaemic stroke; 
NA = unclassified stroke
Table 3: Adjusted hazard ratios (HRs) (with 95% confidence intervals) for the relationship between BMI with CHD in non- and current 
smokers in data that had been left-censored by three years
Smoking Status BMI category (kg/m2) Mean BMI (kg/m2) No. of events Age, sex, study adjusted HR for 
combined fatal and non-fatal CHD 
(95% CI)*
Age, sex, study adjusted HR 
(95% CI) for fatal CHD**
Non 15.0 – 18.4 17.6 46 1.31 (0.97 – 1.77) 1.34 (0.96 – 1.86)
18.5 – 21.9 20.5 201 1.00 (0.87 – 1.15) 1.00 (0.85 – 1.18)
22.0 – 24.9 23.4 457 1.34 (1.22 – 1.47) 1.40 (1.26 – 1.56)
25.0 – 29.9 26.8 699 1.47 (1.36 – 1.59) 1.49 (1.36 – 1.63)
30.0 – 50.0 33.1 245 1.83 (1.61 – 2.09) 1.90 (1.63 – 2.20)
Current 15.0 – 18.4 17.6 29 0.73 (0.50 – 1.06) 0.84 (0.56 – 1.24)
18.5 – 21.9 20.5 237 1.00 (0.88 – 1.14) 1.00 (0.85 – 1.17)
22.0 – 24.9 23.4 326 1.22 (1.10 – 1.36) 1.15 (1.01 – 1.32)
25.0 – 29.9 26.6 362 1.64 (1.47 – 1.82) 1.49 (1.30 – 1.70)
30.0 – 50.0 32.6 104 2.05 (1.68 – 2.51) 2.22 (1.76 – 2.79)
*P-value for interaction between never and current smokers = 0.019
** P-value for interaction between never and current smokers = 0.08Page 5 of 11
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eral of the subgroups. For example, in men, the HRs (95%
CIs) for the risk of unclassified stroke associated with a 2
kg/m2 higher BMI were 1.12 (1.06 – 1.19) for non-smok-
ers and 0.99 (0.93 – 1.06) for smokers; p for interaction
0.005 (Figure 4).
Discussion
This pooled analysis including information on more than
370,000 people confirms the positive log-linear relation-
ship between BMI and CHD and stroke risk in both smok-
ers and never smokers, with no evidence of a threshold
effect within BMIs greater than 18.5 kg/m2. Additionally,
there was some suggestion that the relationship between
BMI and risk of CHD is amplified by the effects of smok-
ing, such that the excess risk for CHD associated with
being overweight in smokers was more than double that
of non-smokers. There was also some evidence to indicate
that the amplification effect of smoking is reversible sub-
sequent to quitting smoking. These findings are consistent
with previous work from our group, which have reported
that smoking may potentiate the effects of other cardio-
vascular risk factors for CHD, including total cholesterol
[21]. In contrast, there was no evidence to indicate that
smoking amplifies the relationship between BMI with
either ischaemic or haemorrhagic stroke. Anomalous to
this finding was the indication that the relationship
between BMI with risk of unclassified stroke may actually
be stronger among non-smokers compared with current
smokers. However, this observation should be treated
more cautiously given the subgroup nature of this analy-
sis, the lack of complete information on the type of stroke
Hazard ratios (HRs) associated with a 2 kg/m2 higher body mass index for coronary heart disease events in current smokers and non-smokers, by ex, region, age and overallFigu e 1
Hazard ratios (HRs) associated with a 2 kg/m2 higher body mass index for coronary heart disease events in cur-
rent smokers and non-smokers, by sex, region, age and overall. Analyses are adjusted by age and stratified by study 
and sex. The horizontal lines (or widths of diamonds for overall results) show 95% confidence intervals (CIs). The p values 
shown are for the test of interaction between body mass index and smoking status. The dashed and continuous lines represent 
current smokers and non-smokers, respectively.
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smoking with either of the major stroke subtypes that are
sure to constitute most of the unclassified strokes.
Comparison with other studies
Earlier findings on this issue are conflicting. Although
there are confirmatory data from previous studies, there
are also several large studies that either reported no inter-
action or a slightly weaker association between BMI and
CHD in smokers compared with non-smokers. For exam-
ple, in a prospective cohort of 220,000 Chinese men, in
whom there were 1240 deaths from ischaemic heart dis-
ease, Chen et al. observed a similar excess risk of CHD
associated with 2 kg/m2 increment in BMI in never and
ever smokers [15]: 1.13 (95% CI: 0.98 – 1.30) and 1.12
(1.02 – 1.22) respectively; p for heterogeneity = 0.9. Sim-
ilarly, in the INTERHEART case-control study there was no
evidence of a significant interaction between BMI and
smoking on the risk of myocardial infarction (MI) in
never, former and current smokers: age and sex-adjusted
odds ratios (95% CI) for MI for 1 SD increase in BMI were
1.12 (1.08 – 1.17), 1.13 (1.06 – 1.19) and 1.17 (1.11 –
1.22), respectively [22]. Whereas, in contrast to our study,
the Nurses' Health Study in the Unites States [23], as well
as other cohort studies from Western countries [14],
observed a rather weaker positive association between
BMI and CHD in current smokers compared to non-
smokers or never smokers, although formal tests for inter-
action were not performed. For example, in the Nurses'
Health Study, the relative risk for CHD comparing women
with BMI ≥ 29 kg/m2 to those with BMI < 21 kg/m2 was
3.26 (95% CI: 2.58 – 4.12) in current smokers compared
Hazard ratios (HRs) associated with a 2 kg/m2 higher body mass index for ischaemic stroke events in current smokers and non-smokers, by ex, region, age and overallFigu e 2
Hazard ratios (HRs) associated with a 2 kg/m2 higher body mass index for ischaemic stroke events in current 
smokers and non-smokers, by sex, region, age and overall. Analyses are adjusted by age and stratified by study and sex. 
The horizontal lines (or widths of diamonds for overall results) show 95% confidence intervals (CIs). The p values shown are 
for the test of interaction between body mass index and smoking status. The dashed and continuous lines represent current 
smokers and non-smokers, respectively.
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BMC Public Health 2009, 9:294 http://www.biomedcentral.com/1471-2458/9/294with 4.36 (95% CI: 3.12 – 6.09) in never or former smok-
ers [23].
The reasons for these discrepant findings are unclear, but
may be due to differences in the age, sex and smoking
characteristics of the populations studied or, alternatively,
to random noise given that the size of any interaction
between BMI and smoking is likely to be relatively small.
Consequently, in order to be able to reliably detect any
effect it would require a sufficiently large sample size and
a diversity of study populations, both are key strengths of
the current analysis. Differences in how smoking is quan-
tified between studies, length of follow-up and the sugges-
tion of an interaction that is only apparent in men [13]
may also explain some of the heterogeneity in study find-
ings. The present study is also not without its limitations,
one of which is the lack of information on changes in BMI
and smoking status during follow-up. However, any
potential changes, particularly those relating to smoking
(for example, quitting smoking during follow-up) would
have resulted in an underestimation of the synergistic
relationship between BMI and smoking. Moreover, we
had limited, or no, data on both the quantity of cigarettes
smoked and the duration of smoking, which are both key
determinants of the magnitude of the smoking hazard.
Furthermore, we were limited to using BMI, a measure of
general adiposity, whereas central adiposity is considered
to be more closely associated with metabolic disorders
Hazard ratios (HRs) associated with a 2 kg/m2 higher body mass index for haemorrhagic stroke events in current smokers and non-smokers, by sex, region, age and overallFigu e 3
Hazard ratios (HRs) associated with a 2 kg/m2 higher body mass index for haemorrhagic stroke events in cur-
rent smokers and non-smokers, by sex, region, age and overall. Analyses are adjusted by age and stratified by study 
and sex. The horizontal lines (or widths of diamonds for overall results) show 95% confidence intervals (CIs). The p values 
shown are for the test of interaction between body mass index and smoking status. The dashed and continuous lines represent 
current smokers and non-smokers, respectively.
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waist circumference and waist to hip ratio, which are bet-
ter indicators of central obesity. As current smokers have
been reported to have a higher abdominal fat distribution
profile, in spite of their lower BMI, compared to never
smokers [25,26], it may be that the effects of smoking are
more apparent if indices of central obesity are used [26-
28].
Excess weight is indirectly, and possibly directly, associ-
ated with CHD through its adverse effects on blood pres-
sure, lipids and glucose metabolism [29,30]. These known
coronary risk factors promote atherosclerosis of the coro-
nary arteries in the causal pathway between adiposity and
CHD. One possible pathophysiological explanation for
the observed synergism is that smoking and one or more
of the adiposity-induced metabolic disorders may interact
to promote coronary atherosclerosis. Alternatively, smok-
ing may affect another as yet unknown pathway between
excess weight and CHD risk independent of known meta-
bolic abnormalities.
Conclusion
In conclusion, our data re-emphasize the importance of
appropriate lifestyles and risk factor management for the
prevention of CHD. Even though the amplification effect
Hazard ratios (HRs) associated with a 2 kg/m2 higher body mass index for unclassified stroke events in current smokers and non-smokers, by sex, region, age and overallFigu e 4
Hazard ratios (HRs) associated with a 2 kg/m2 higher body mass index for unclassified stroke events in current 
smokers and non-smokers, by sex, region, age and overall. Analyses are adjusted by age and stratified by study and sex. 
The horizontal lines (or widths of diamonds for overall results) show 95% confidence intervals (CIs). The p values shown are 
for the test of interaction between body mass index and smoking status. The dashed and continuous lines represent current 
smokers and non-smokers, respectively.
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BMC Public Health 2009, 9:294 http://www.biomedcentral.com/1471-2458/9/294of smoking on the BMI-CHD relation is relatively small,
given the widespread prevalence of smoking and excess
weight (1 billion and 1.7 billion people, respectively), the
population attributable risk is considerable. Thus, strate-
gies to curb both smoking and promote weight loss at the
population level could have a greater impact on reducing
the burden of CHD than previously anticipated.
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